PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 3, 20261 citations

Retinal microvascular changes in patients with ankylosing spondylitis receiving biologic therapy: a cross-sectional OCTA study.

View Full Paper
RSRumeysa SamanciBMBayram MeydanKTKuddusi Teberik

Key Points

  • This study aims to evaluate retinal microcirculation in ankylosing spondylitis patients receiving biologic therapy and its relationship with disease activity.
  • Cross-sectional study involving 57 ankylosing spondylitis patients under biologic therapy and 57 healthy controls.
  • Optical coherence tomography angiography imaging of the right eyes assessed various retinal metrics.
  • Parameters included vessel area density, foveal avascular zone metrics, and vessel density for superficial and deep vascular complexes.
  • Parafoveal superficial vascular complex vessel area density was reduced in active AS (p = 0.007).
  • Deep vascular complex metrics showed significantly lower values in both AS groups compared to controls (all p < 0.01).
  • Overall retinal thickness and structural measurements remained similar across groups (all p > 0.05).

Abstract

BACKGROUND: To evaluate retinal microcirculation in biologic-treated ankylosing spondylitis (AS) using optical coherence tomography angiography (OCTA) and its association with disease activity. METHODS: Fifty-seven AS patients (31 active, 26 inactive) under biologic therapy and 57 age- and sex-matched healthy controls were included. Right eyes underwent 10°×10° macular OCTA imaging (Heidelberg Spectralis). Vessel area density (VAD), foveal avascular zone (FAZ) metrics, and vessel density within a 300-µm-wide ring surrounding the FAZ (FD-300) were quantified for the superficial and deep vascular complexes (SVC and DVC). Structural OCT provided foveal and parafoveal retinal thickness, peripapillary retinal nerve fiber layer (RNFL), and subfoveal choroidal thickness. Biologic therapy details and disease activity indices (Ankylosing Spondylitis Disease Activity Score-C-reactive protein ASDAS-CRP, Bath Ankylosing Spondylitis Disease Activity Index BASDAI, Bath Ankylosing Spondylitis Functional Index BASFI) were obtained from records. OCTA and structural parameters were compared among active AS, inactive AS, and control groups. RESULTS: Parafoveal SVC VAD was reduced only in the active AS group (p = 0.007), whereas DVC total/parafoveal VAD and FD-300 values were lower in both AS groups compared with controls (all p 0.05). For distinguishing AS patients from controls, DVC metrics showed the highest performance (AUC ≈ 0.70-0.73; 0.63 for SVC), while the combined model including age, sex, and OCTA parameters achieved an AUC of 0.77. For differentiating disease activity, DVC-FAZ alone showed limited performance (AUC = 0.67). A parsimonious multivariable model including age, sex, BASFI, and DVC FAZ area yielded an AUC of 0.88 (95% CI: 0.80-0.97). CONCLUSIONS: In AS patients receiving biologic therapy, retinal microcirculatory alterations were detected-particularly within the DVC-while retinal and choroidal structural measurements appeared to remain largely preserved. Further studies are warranted to confirm these findings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Samanci et al. (2026) studied this question.

synapsesocial.com/papers/69f6e5f38071d4f1bdfc68d3https://doi.org/10.1186/s12886-026-04866-x
Ask AI
Helpful
Bookmark
Share
View Full Paper